At VaLogic, we have the resources and experience to assist with meeting USP’s standards for compounding non-sterile drugs (including creams, lotions, capsules and pills), helping to ensure patient benefits and reduce risks.
VaLogic can provide assistance in meeting USP’s standards for compounding sterile drugs (which are delivered through injection or intravenous infusion), helping to ensure patient benefits and reduce risks.
In General Chapter <800>, USP outlines standards for the safe handling and compounding of hazardous drugs (such as those used in chemotherapy). VaLogic is sufficiently equipped to help individuals and organizations meet these standards.
VaLogic is adequately trained, licensed and certified to help pharmacies meet the FDA’s requirements to be designated 503-A compounding pharmacies. 503-A pharmacies are limited to compounding for individual use and do not work in large batches.
VaLogic is adequately trained, licensed and certified to help pharmacies meet the FDA’s requirements to be designated 503-A compounding pharmacies. 503-A pharmacies are limited to compounding for individual use and do not work in large batches.